Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial

被引:556
|
作者
Wawer, MJ
Sewankambo, NK
Serwadda, D
Quinn, TC
Paxton, LA
Kiwanuka, N
Wabwire-Mangen, F
Li, CJ
Lutalo, T
Nalugoda, F
Gaydos, CA
Moulton, LH
Meehan, MO
Ahmed, S
Gray, RH
机构
[1] Columbia Univ, Sch Publ Hlth, Ctr Populat & Family Hlth, New York, NY 10032 USA
[2] Makerere Univ, Dept Med, Kampala, Uganda
[3] Makerere Univ, Clin Epidemiol Unit, Kampala, Uganda
[4] Makerere Univ, Inst Publ Hlth, Dept Populat & Family Hlth Sci, Kampala, Uganda
[5] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD 21205 USA
[6] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD 21205 USA
[7] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[8] Uganda Virus Res Inst, Rakai Project, Entebbe, Uganda
[9] NIAID, Bethesda, MD 20892 USA
来源
LANCET | 1999年 / 353卷 / 9152期
关键词
D O I
10.1016/S0140-6736(98)06439-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The study tested the hypothesis that community-level control of sexually transmitted disease (STD) would result in lower incidence of HIV-1 infection in comparison with control communities. Methods This randomised, controlled, single-masked, community-based trial of intensive STD control, via home-based mass antibiotic treatment, took place in Rakai District, Uganda. Ten community clusters were randomly assigned to intervention or control groups. All consenting residents aged 15-59 years were enrolled; visited in the home every 10 months; interviewed; asked to provide biological samples for assessment of HIV-1 infection and STDs; and were provided with mass treatment (azithromycin, ciprofloxacin, metronidazole in the intervention group, vitamins/anthelmintic drug in the control). intention-to-treat analyses used multivariate, paired, cluster-adjusted rate ratios. Findings The baseline prevalence of HIV-1 infection was 15.9%. 6602 HIV-1-negative individuals were enrolled in the intervention group and 6124 in the control group. 75.0% of intervention-group and 72.6% of control-group participants provided at least one follow-up sample for HIV-1 testing. At enrolment, the two treatment groups were similar in STD prevalence rates. At 20-month follow-up, the prevalences of syphilis (352/6238 [5.6%) vs 359/5284 [6.8%]; rate ratio 0.80 [95% CI 0.71-0.89]) and trichomoniasis (182/1968 [9.3%] vs 261/1815 [14.4%]; rate ratio 0.59 [0.38-0.91]) were significantly lower in the intervention group than in the control group. The incidence of HIV-1 infection was 1.5 per 100 person-years in both groups (rate ratio 0.97 [0.81-1.16]). In pregnant women, the follow-up prevalences of trichomoniasis, bacterial vaginosis, gonorrhoea, and chlamydia infection were significantly lower in the intervention group than in the control group. No effect of the intervention on incidence of HIV-1 infection was observed in pregnant women or in stratified analyses. Interpretation We observed no effect of the STD intervention on the incidence of HIV-1 infection. In the Rakai population, a substantial proportion of HIV-1 acquisition appears to occur independently of treatable STD cofactors.
引用
收藏
页码:525 / 535
页数:11
相关论文
共 50 条
  • [1] A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda
    Wawer, MJ
    Gray, RH
    Sewankambo, NK
    Serwadda, D
    Paxton, L
    Berkley, S
    McNairn, D
    Wabwire-Mangen, F
    Li, CJ
    Nalugoda, F
    Kiwanuka, N
    Lutalo, T
    Rookmeyer, R
    Kelly, R
    Quinn, TC
    AIDS, 1998, 12 (10) : 1211 - 1225
  • [2] PREVENTION OF SEXUALLY-TRANSMITTED DISEASES - A RANDOMIZED COMMUNITY TRIAL
    MEYER, L
    JOBSPIRA, N
    BOUYER, J
    BOUVET, E
    SPIRA, A
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1991, 45 (02) : 152 - 158
  • [3] PREVENTION OF AIDS AND SEXUALLY-TRANSMITTED DISEASES
    BOHBOT, JM
    ADVANCES IN GYNECOLOGY AND OBSTETRICS SERIES, VOL 6: GENERAL GYNECOLOGY, 1989, : 25 - 32
  • [4] Community understanding and prevention of sexually transmitted diseases
    Oumeish, OY
    Oumeish, IF
    CLINICS IN DERMATOLOGY, 2004, 22 (06) : 533 - 536
  • [5] COUNSELING FOR THE PREVENTION OF SEXUALLY-TRANSMITTED DISEASES AND AIDS
    DOMINGUEZ, A
    CAPDEVILA, JM
    SANZ, B
    BARRABEIG, I
    RODES, A
    CASABONA, J
    SALLERAS, M
    TABERNER, JL
    MEDICINA CLINICA, 1994, 102 : 118 - 126
  • [6] Prevention Behavior to Sexually Transmitted Diseases and AIDS of University Students
    Ounjit , Wilailak
    International Conference on Education & Educational Psychology 2013 (ICEEPSY 2013), 2014, 112 : 525 - 531
  • [7] The "PREVEN" urban community randomised trial of a combined intervention for sexually transmitted disease prevention in Nepal
    Bhandari, R. P.
    Joshi, S. D.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E411 - E412
  • [8] Roles for pharmacists in the prevention and control of sexually transmitted diseases
    Stergachis, A
    SEXUALLY TRANSMITTED DISEASES, 1999, 26 (04) : S44 - S47
  • [9] PREVENTION OF SEXUALLY TRANSMITTED DISEASES
    BRECHER, EM
    JOURNAL OF SEX RESEARCH, 1975, 11 (04) : 318 - 328
  • [10] THE PREVENTION OF SEXUALLY-TRANSMITTED DISEASES AND AIDS THROUGH THE USE OF CONDOMS
    DELRIOCHIRIBOGA, C
    URIBEZUNIGA, P
    SALUD PUBLICA DE MEXICO, 1993, 35 (05): : 508 - 517